ArticleJCO global oncology2020
Outcome of Oncology Patients Infected With Coronavirus.
Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.
- A mixed-method analysis to identify the current focus, trends, and gaps in health science research in Saudi Arabia.Frontiers in public health · 2022Pooled it
- The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.Cerebrovascular diseases (Basel, Switzerland) · 2021Pooled it
- Seroprevalence of SARS-CoV-2 and Hepatitis B Virus Coinfections among Ethiopians with Acute Leukemia.Cancers · 2024Article
- Impact and control of the COVID pandemic in an elite sports club: Real Madrid.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023Article
- Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report.Journal of cardiovascular development and disease · 2022Review
- Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson's Disease Affected by COVID-19: A Narrative Review.Diagnostics (Basel, Switzerland) · 2022Review
- Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent Correlation.Journal of oncology · 2022Review
- Patients affected by squamous cell carcinoma of the head and neck: A population particularly prone to developing severe forms of COVID-19.Experimental and therapeutic medicine · 2021Article
- Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities.Thoracic cancer · 2021Review
- Article
- COVID-19 and Global Oncology: A Year in Review.JCO global oncology · 2021Article
- A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence.Computers in biology and medicine · 2021Review
- Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.JNCI cancer spectrum · 2021Article
- The Deadly Duo of COVID-19 and Cancer!Frontiers in molecular biosciences · 2021Review
- Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic.Cancer medicine · 2020Review
- Mitigating strategies and nursing response for cancer care management during the COVID-19 pandemic: an Italian experience.International nursing review · 2020Article
- COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
- An investigation into the molecular basis of cancer comorbidities in coronavirus infection.FEBS open bio · 2020Article
- Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.Critical reviews in oncology/hematology · 2020Review
- Management of cancer patients during COVID-19 pandemic at developing countries.World journal of clinical cases · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigated the features of oncology patients with confirmed Middle East respiratory syndrome (MERS) at the Ministry of National Guard Health Affairs-Riyadh during the outbreak of June 2015 to determine the clinical course and outcome of affected patients.
methodsThe patients' demographic information, cancer history, treatment pattern, information about MERS-coronavirus (CoV) infection, history of travel, clinical symptoms, test results, and outcome were collected and analyzed as part of a quality improvement project to improve the care and safety of our patients. Only patients with confirmed infection were included.
resultsA total of 19 patients were identified, with a median age of 66 years (range, 16-88 years), and 12 patients (63%) were males. The most common underlying disease was hematologic malignancies (47.4%), followed by colorectal cancer (21%) and lung cancer (15.8%). Hypertension and diabetes mellitus were the most common comorbidities (57.9% and 52.6%, respectively). Infection was diagnosed by nasopharyngeal swab in all patients. All patients contracted the infection during their hospitalization for other reasons. Sixteen patients (80%) were admitted to the intensive care unit; 13 patients (81%) had acute respiratory distress syndrome, 11 were intubated (68.75%), 9 had acute renal injury (56.25%), and 3 required dialysis (18.75%). Only 3 patients (15.8%) with early-stage cancers survived. Patients with hematologic malignancies and advanced solid tumors had a 100% case fatality rate. The majority of the causes of death were due to multi-organ failure and septic shock.
conclusionMERS-CoV infection resulted in a high case fatality rate in patients with malignancy. Therefore, it is critical to implement effective primary preventive measures to avoid exposure of patients with cancer to the virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.